Table 3

 Proportion of CSF samples with normal or abnormal clinical or laboratory findings in which virus was detected by PCR

Symptom, sign, or laboratory investigation*Finding present (%)Finding absent (%)Odds ratio (95% CI)p Value
*Not all clinical or laboratory features were recorded for each patient; †odds ratio calculated by comparison of findings in <3 days group with subsequent groups.
CSF, cerebrospinal fluid; EEG, electroencephalogram; NS, not significant; WCC, white cell count.
Fever (⩾37.5°C)30/199 (15%)21/224 (9%)1.72 (0.94 to 3.15)NS
Meningism14/75 (19%)41/408 (10%)2.05 (1.04 to 4.05)0.0498
Headache27/160 (17%)15/225 (7%)2.84 (1.44 to 5.62)0.0027
Rash8/50 (16%)46/429 (11%)1.59 (0.69 to 3.65)NS
Focal neurology8/113 (7%)47/370 (13%)0.52 (0.24 to 1.16)NS
Seizures13/127 (10%)41/352 (12%)0.86 (0.44 to 1.70)NS
Encephalopathy14/139 (10%)36/313 (12%)0.86 (0.44 to 1.68)NS
Immunosuppression11/71 (16%)44/410 (11%)1.53 (0.74 to 3.16)NS
Abnormal CNS imaging14/161 (9%)21/194 (11%)0.78 (0.38 to 1.62)NS
Abnormal EEG12/89 (14%)4/20 (20%)0.62 (0.17 to 2.24)NS
Abnormal CSF WCC24/128 (19%)29/344 (8%)2.51 (1.38 to 4.55)0.0028
Abnormal CSF protein23/132 (17%)25/311 (8%)2.41 (1.30 to 4.49)0.0062
Delay between onset of symptoms and lumbar puncture†
    <3 days6/101 (6%)
    3 to <7 days19/99 (19%)0.270 (0.10 to 0.71)0.0088
    7 to <14 days15/90 (16%)0.32 (0.11 to 0.87)0.0329
    ⩾14 days2/92 (2%)2.84 (0.54 to 14.94)NS